Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research (Q30995022)

28 June 2017

1 reference

title

Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research (English)

1 reference

28 June 2017

1 reference

1 reference

Stork C

1

1 reference

PubMed ID

16027739

28 June 2017

Renshaw PF

series ordinal

2

1 reference

PubMed ID

16027739

28 June 2017

language of work or name

English

0 references

publication date

1 October 2005

1 reference

28 June 2017

1 reference

28 June 2017

10

1 reference

28 June 2017

900-919

1 reference

28 June 2017

10

1 reference

Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder

28 June 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

N-acetyl-L-aspartic acid: a literature review of a compound prominent in 1H-NMR spectroscopic studies of brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Lower Concentration of HippocampalN-Acetylaspartate in Familial Bipolar I Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Synthesis of N-acetyl-l-aspartate by rat brain mitochondria and its involvement in mitochondrial/cytosolic carbon transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

N-Acetylation of L-aspartate in the nervous system: differential distribution of a specific enzyme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

N-acetyl aspartate: a marker for neuronal loss or mitochondrial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

N-acetylaspartate in the vertebrate brain: metabolism and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Characterization of the N-acetylaspartate biosynthetic enzyme from rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

1H and 31P magnetic resonance spectroscopy of the brain in degenerative cerebral disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

N-Acetylaspartate reduction as a measure of injury severity and mitochondrial dysfunction following diffuse traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

N-Acetylaspartate, a marker of both cellular dysfunction and neuronal loss: its relevance to studies of acute brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Frontal lobe differences in bipolar disorder as determined by proton MR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Decreased N-acetylaspartate in children with familial bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Chronic lithium and sodium valproate both decrease the concentration of myo-inositol and increase the concentration of inositol monophosphates in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Proton magnetic resonance spectroscopy of the brain in schizophrenic and affective patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Chronic treatment with lithium, but not sodium valproate, increases cortical N-acetyl-aspartate concentrations in euthymic bipolar patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

1H MRS study of dorsolateral prefrontal cortex in healthy individuals before and after lithium administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Lithium and valproic acid treatment effects on brain chemistry in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Proton magnetic resonance spectroscopy of the lenticular nuclei in bipolar I affective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Quantitative proton magnetic resonance spectroscopy of the bilateral frontal lobes in patients with bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Increased thalamic N-acetylaspartate in male patients with familial bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Glial reduction in the subgenual prefrontal cortex in mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Alterations in brain phosphorus metabolite concentrations associated with areas of high signal intensity in white matter at MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

What might be the impact on neurology of the analysis of brain metabolism by in vivo magnetic resonance spectroscopy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Phosphorus-31 magnetic resonance spectra reveal prolonged intracellular acidosis in the brain following subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Ischemic delayed neuronal death. A mitochondrial hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Mitochondria in neurodegeneration: acute ischemia and chronic neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Mitochondrial permeability transition in acute neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Mitochondria accumulate Ca2+ following intense glutamate stimulation of cultured rat forebrain neurones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Reduced intracellular pH in the basal ganglia and whole brain measured by 31P-MRS in bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Alterations in brain phosphorous metabolism in bipolar disorder detected by in vivo 31P and 7Li magnetic resonance spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Brain phosphorous metabolism in depressive disorders detected by phosphorus-31 magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Decreased brain intracellular pH measured by 31P-MRS in bipolar disorder: a confirmation in drug-free patients and correlation with white matter hyperintensity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Reduction of brain phosphocreatine in bipolar II disorder detected by phosphorus-31 magnetic resonance spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Phosphorus-31 magnetic resonance spectroscopy and ventricular enlargement in bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Prediction of lithium response by 31P-MRS in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Mitochondrial dysfunction in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Effects of noradrenaline on intracellular pH in acutely dissociated adult rat hippocampal CA1 neurones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Proton magnetic resonance spectroscopy for the diagnosis and management of cerebral disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Functional evaluation techniques in mitochondrial disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Induced mitochondrial failure in the feline brain: implications for understanding acute post-traumatic metabolic events

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Brain metabolic alterations in medication-free patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Acute mania is accompanied by elevated glutamate/glutamine levels within the left dorsolateral prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Nonlinear decrease over time in N-acetyl aspartate levels in the absence of neuronal loss and increases in glutamine and glucose in transgenic Huntington's disease mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Morphologic and histochemical characteristics of a spared subset of striatal neurons in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Proton magnetic resonance spectroscopy in Huntington's disease: evidence in favour of the glutamate excitotoxic theory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

21 January 2018

ATP and brain function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Effect of photic stimulation on energy metabolism in the human brain measured by 31P-MR spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Ethanolamine and phosphoethanolamine inhibit mitochondrial function in vitro: implications for mitochondrial dysfunction hypothesis in depression and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Phosphorus magnetic resonance spectroscopy of patients with mitochondrial cytopathies demonstrates decreased levels of brain phosphocreatine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Defective brain energy metabolism shown by in vivo 31P MR spectroscopy in 28 patients with mitochondrial cytopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Abnormal brain and muscle energy metabolism shown by 31P magnetic resonance spectroscopy in patients affected by migraine with aura

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Energy requirements for two aspects of phospholipid metabolism in mammalian brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Proton NMR chemical shifts and coupling constants for brain metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Developmental changes in choline- and ethanolamine-containing compounds measured with proton-decoupled (31)P MRS in in vivo human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Lack of effect of oral choline supplement on the concentrations of choline metabolites in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Differentiation of metabolic concentrations between gray matter and white matter of human brain by in vivo 1H magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

The source of choline for acetylcholine synthesis in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

A review of chemical issues in 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Choline phospholipid metabolism: a target in cancer cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Acceleration of phosphatidylcholine synthesis and breakdown by inhibitors of mitochondrial function in neuronal cells: a model of the membrane defect of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Erythrocyte choline concentrations in psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Brain choline concentrations may not be altered in euthymic bipolar disorder patients chronically treated with either lithium or sodium valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Magnetic resonance spectroscopy of the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Biochemical considerations in1H spectroscopy. Glutamate and glutamine;Myo-inositol and related metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Multinuclear NMR studies on the energy metabolism of glial and neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Magnetic resonance spectroscopy in affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Human cerebral osmolytes during chronic hyponatremia. A proton magnetic resonance spectroscopy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Reduced Brain Inositol in Lithium-treated Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Modulation of protein kinase C isozymes and substrates by lithium: the role of myo-inositol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Neural and developmental actions of lithium: a unifying hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Changes in the 31P-NMR spectra of cats receiving lithium chloride systemically.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Chronic treatment with both lithium and sodium valproate may normalize phosphoinositol cycle activity in bipolar patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Proton magnetic resonance spectroscopy of bipolar disorder versus intermittent explosive disorder in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Phosphorylethanolamine--the major constituent of the phosphomonoester peak observed by 31P-NMR on developing dog brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Phosphorus-31 magnetic resonance spectroscopic observations in 4 cases with anorexia nervosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Localized phosphorus 31 magnetic resonance spectroscopy in chronic schizophrenic patients and normal controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

In vivo brain (31)P-MRS: measuring the phospholipid resonances at 4 Tesla from small voxels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

31P Nuclear magnetic resonance spectroscopy findings in bipolar illness: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Measurement of brain phosphoinositide metabolism in bipolar patients using in vivo 31P-MRS

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Abnormalities of cAMP signaling in affective disorders: implication for pathophysiology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Abnormalities in protein kinase C signaling and the pathophysiology of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Intracellular calcium signaling systems in the pathophysiology of affective disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Evidence for common alterations in cerebral glucose metabolism in major affective disorders and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Regional cerebral blood flow in patients with affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Subgenual prefrontal cortex abnormalities in mood disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Reduction of prefrontal cortex glucose metabolism common to three types of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Cerebral metabolic rates for glucose in mood disorders. Studies with positron emission tomography and fluorodeoxyglucose F 18.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

SPECT findings in patients with primary mania.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Regional cerebral blood flow in mood disorders: IV. Comparison of mania and depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Increased anterior cingulate and caudate activity in bipolar mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Increased levels of a mitochondrial DNA deletion in the brain of patients with bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Molecular evidence for mitochondrial dysfunction in bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Using advances in neuroimaging to detect, understand, and monitor disease progression in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Creatine therapy provides neuroprotection after onset of clinical symptoms in Huntington's disease transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Bioenergetic approaches for neuroprotection in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Prophylactic creatine administration mediates neuroprotection in cerebral ischemia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Effect of valproate on the metabolism of the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Differential effects of typical and atypical neuroleptics on mitochondrial function in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Inhibition of mitochondrial complex I by haloperidol: the role of thiol oxidation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Protein thiol oxidation by haloperidol results in inhibition of mitochondrial complex I in brain regions: comparison with atypical antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Energy thresholds in brain mitochondria. Potential involvement in neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

Reversible decreases in N-acetylaspartate after acute brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

7 January 2021

Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

7 January 2021

Proton MR spectroscopic characterization of differences in regional brain metabolic abnormalities in mitochondrial encephalomyopathies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

7 January 2021

Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

7 January 2021

High vesicular monoamine transporter binding in asymptomatic bipolar I disorder: sex differences and cognitive correlates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

7 January 2021

Mitochondrial dysfunction is a primary event in glutamate neurotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

7 January 2021

Mitochondrial depolarization in glutamate-stimulated neurons: an early signal specific to excitotoxin exposure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

7 January 2021

Localized 13C NMR spectroscopy in the human brain of amino acid labeling from D-[1-13C]glucose

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

7 January 2021

Lateralized abnormality of high energy phosphate metabolism in the frontal lobes of patients with bipolar disorder detected by phase-encoded 31P-MRS

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

7 January 2021

Role of mitochondrial Ca2+ regulation in neuronal and glial cell signalling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

7 January 2021

Mitochondrial genotype associated with longevity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

7 January 2021

Association of bipolar disorder with the 5178 polymorphism in mitochondrial DNA

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

7 January 2021

Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001711

7 January 2021

Identifiers

DOI

10.1038/SJ.MP.4001711

1 reference

28 June 2017

1 reference

PubMed ID

16027739